SCHEMBL4150984

SCHEMBL4150984

N#Cc1c(-c2ccc(F)cc2F)[nH]c2ccc(S(=O)(=O)c3ccccc3)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.43
HTR2C P28335 2/20 0.43
KCNH2 Q12809 2/20 0.43
PTGS2 P35354 3/20 0.41
PDE9A O76083 1/20 0.40
HTR6 P50406 3/20 0.40
ADORA1 P30542 2/20 0.38
ADORA2A P29274 1/20 0.38
CXCR2 P25025 2/20 0.37
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4151365 0.72 HTR2A (0.48) HTR2AHTR2CKCNH2ALDH1A1KDM4E
SCHEMBL3164357 0.66 HTR2A (0.70) HTR2AHTR2CKCNH2PTGS2MEN1
Pyridine SCHEMBL28512865 0.66 BRAF (0.44) HTR2APTGS2HTR6ALDH1A1KDM4E
SCHEMBL3164364 0.66 HTR2A (0.70) HTR2AHTR2CKCNH2PTGS2MEN1
SCHEMBL3390895 0.66 HTR2A (0.51) HTR2AHTR2CKCNH2HTR6ALDH1A1
SCHEMBL28028239 0.65 FASN (0.45) CXCR2ALDH1A1MEN1HPGDKMT2A
SCHEMBL1993674 0.65 HTR2A (0.50) HTR2AHTR2CKCNH2HTR6ALDH1A1
SCHEMBL4069294 0.65 ABL1 (0.45) HTR2AHTR2CKCNH2PTGS2MEN1
SCHEMBL15330358 0.64 PIM1 (0.45) PTGS2ALDH1A1KDM4EGLAGAA
SCHEMBL11686034 0.64 HTR6 (0.44) PTGS2HTR6CA1CA2FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090012134-A1 Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists CURTIS NEIL ROY 2009-01-08 US claimed
US-20090012134-A1 Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists CURTIS NEIL ROY 2009-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012134-A1 Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists HTR2A, HTR2C, HTR2B HTR2A 1/4885HTR2C 2/4885KCNH2 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.